Timothy T. Lu
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Cancer Genomics and Diagnostics, Microscopic Colitis, Histiocytic Disorders and Treatments, Genetic Associations and Epidemiology
Most-Cited Works
- → Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors(2000)1,462 cited
- → Vitamin D Receptor As an Intestinal Bile Acid Sensor(2002)1,149 cited
- → Correlation between Genetic and Geographic Structure in Europe(2008)515 cited
- → Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus(2008)458 cited
- → Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial(2014)451 cited
- → The role of IL-22 in intestinal health and disease(2020)429 cited
- → Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism(2001)356 cited
- → The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis(2015)275 cited
- → Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme(2013)210 cited
- → Genomic and geographic distribution of SNP-defined runs of homozygosity in Europeans(2010)194 cited